Showing results (41-50 of 137) with videos related to
Sort By:
Pageof 14
Gut|September 24, 2010
Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis CRami Moucari, Nicole Forestier, Dominique Larrey, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2013
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirinPeter Ferenci, Rodrigo Aires, Ioan Ancuta, et al.Journal of Hepatology|December 15, 2010
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose studyNicole Forestier, Dominique Larrey, Dominique Guyader, et al.The Pharmacogenomics Journal|February 7, 2020
HLA associations with infliximab-induced liver injuryChristopher D Bruno, Brandon Fremd, Rachel J Church, et al.Journal of Clinical Microbiology|June 22, 2007
Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assayEdouard Tuaillon, Anne-Marie Mondain, Laure Ottomani, et al.Journal of Hepatology|April 26, 2003
Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?Georges-Philippe Pageaux, Michael Bismuth, Pascal Perney, et al.Transplantation|November 20, 2002
Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsChristophe Duvoux, Georges-Philippe Pageaux, Claire Vanlemmens, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2026
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to FluoroquinolonesPaola Nicoletti, M Isabel Lucena, Raul J Andrade, et al.Multiple Sclerosis and Related Disorders|October 16, 2025
Identification of risk profiles for liver injury in adults with multiple sclerosis using artificial intelligence methodDominique Larrey, Fang Liz Zhou, Claire Brulle-Wohlhueter, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2006
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantationGeorges-Philippe Pageaux, Lionel Rostaing, Yvon Calmus, et al.Pageof 14